A number of studies dedicated to GLP-1RA efficacy in T2D included patients with chronic HF (CHF) (16.2% in the EXSCEL trial, 23.6% in SUSTAIN-6, 12.2% in PIONEER, 8.6% in REWIND, 20% in Harmony, 22% in ELIXA and 18% in LEADER)
Remember, every patients experience is unique
The mechanism is not fully pinned down, and reports are largely anecdotal so far
Your cost depends on the form of semaglutide you choose: once-weekly injections or a daily tablet
Can I take this supplement with other medications
Potential Risks and Safety Concerns of Stacking Peptides Combining retatrutide with other peptides introduces unpredictable risks including hypoglycaemia, hormonal disruption, elevated IGF-1, cardiovascular effects, and infection from non-sterile self-injection